Primera Antena
La primera Antena corresponde al debate sobre la perspectiva social en la evaluación de innovaciones sanitarias, tanto en el ámbito de los medicamentos como de las tecnologías, abordando cuestiones como:
- ¿Cuál es la medida adecuada de los beneficios en productividad?
- Más allá de la productividad, ¿qué se puede medir dentro de la perspectiva social?
- ¿A nivel nacional deben establecerse las directrices sobre qué se considera un beneficio o un coste social, o es necesaria una homogeneización de criterios?
- ¿Cuál es el panorama internacional en esta materia? ¿Cómo podrían adaptarse las mejores prácticas al sistema de evaluación español?
Llistat d'articles seleccionats
- The societal perspective in health assessment
- Nurturing societal values in and through health innovations: Comment on" What health system challenges should responsible innovation in health address?"
- Estimating and rewarding the value of healthcare interventions beyond the healthcare sector: a conceptual framework
- The long and winding road towards payment for healthcare innovation with high societal value but limited commercial value: A comparative case study of devices and health information technologies
- How is the societal perspective defined in health technology assessment? Guidelines from around the globe
- HTA243 Guidelines for Incorporating the Societal Perspective and Wider Societal Benefits in Health Technology Assessment
- A review of HTA guidelines on societal and novel value elements
- All health is not equal: the use of modifiers in NICE technology appraisal
- Benefits beyond health in the willingness to pay for a quality-adjusted life-year
- What Does ‘Whole Health’ Really Mean for Health Economics and Outcomes Research?
- Five pillars for societal perspective
- Adoption of a Societal Perspective in Economic Evaluations of Musculoskeletal Disorders: A Conceptual Paper
- Methods for Early Assessment of the Societal Value of Health Technologies: A Scoping Review and Proposal for Classification
- Health economic evaluation of digital nursing technologies: a review of methodological recommendations
- Methodological considerations for estimating indirect costs in children and adolescents with chronic conditions: a scoping review
- Detection of potential causal pathways among social determinants of health: A data-informed framework
- Examining how well economic evaluations capture the value of mental health
- Value is Gendered: The Need for Sex and Gender Considerations in Health Economic Evaluations
- Different attitudes towards estimating indirect costs of disease: The example of cancer
- Taking health economics and outcomes research forward: expanding the definition of value to include whole health
- Assessing the health and welfare benefits of interventions using the Wider Societal Impacts framework
- How innovation can be defined, evaluated and rewarded in health technology assessment
- PD69 Road Map Of Health Equity Considerations In Health Technology Assessments: Identifying The Evidence From Epidemiology To Health Economics
- A Comprehensive View of the Methods Used to Measure the Societal Impact of Healthcare Interventions: A Systematic Review
- The Health Innovation Impact Checklist: a tool to improve the development and reporting of impact models for global health innovations
- Considering severity in health technology assessment: can we do better?
- Measurement and valuation of the attributes of innovation of healthcare technologies: a systematic review
- The application of social innovation in healthcare: a scoping review
- Striving for a societal perspective: a framework for economic evaluations when costs and effects fall on multiple sectors and decision makers
- Value assessment and decision-making: how to move health systems forward?
- Public spending
- Measurement of productivity
- Routine measurement in low back pain; towards a pragmatic patient-reported productivity cost outcome measurement using the institute for medical technology assessment productivity cost questionnaire
- Moving forward with taking a societal perspective: a themed issue on productivity costs, consumption costs and informal care costs
- Measurement instruments of productivity loss of paid and unpaid work: a systematic review and assessment of suitability for health economic evaluations from a societal perspective
- Incorporating productivity loss in health economic evaluations: a review of guidelines and practices worldwide for research agenda in China
- Integrating economic, environmental and societal performance within the productivity measurement
- Associating health-related quality-of-life score with time uses to inform productivity measures in cost-effectiveness analysis
- Systematic literature review of the use of productivity losses/gains in cost-effectiveness analyses of immune-mediated disorders
- Measuring, analyzing, and presenting work productivity loss in randomized controlled trials: a scoping review
- Societal return and public health impact
- Integration of Social Return on Investment with Health Impact Assessment and evaluation frameworks
- Capturing the social value and return on investment of public health services and interventions
- Capturing the value of vaccination within health technology assessment and health economics: Literature review and novel conceptual framework
- Presenting a social value database and simulator for public health
- Merits of the social return on investment methodology for assessing the value of palliative care programmes
- Capturing the value of vaccination within health technology assessment and health economics: Country analysis and priority value concepts
- The development of the concept of return-on-investment from large-scale quality improvement programmes in healthcare: an integrative systematic literature review
- Analyses of the return on investment of public health 7 interventions: a scoping review and recommendations for future studies
- Balancing clinical benefit and social value: challenges in HTA assessments
- Real-world effectiveness vs. clinical trial results
- Use of Real-World Evidence in Health Technology Reassessments Across Six Health Technology Assessment Agencies
- Health technology assessment for in silico medicine: social, ethical and legal aspects
- Real-world evidence to reinforce clinical trial evidence in health technology assessment: a critical review of real-world evidence requirements from seven countries and recommendations to improve acceptance
- Spillover effects on family and caregivers
- Food for thought: more explicit guidance for inclusion of caregiver perspectives in health technology assessment
- Development of stakeholder-informed recommendations for inclusion of family spillover effects in health technology assessment
- Indirect costs of Alzheimer’s disease: unpaid caregiver burden and patient productivity loss
- Addressing the distributional consequences of spillovers in health economic evaluation: A prioritarian approach
- Recommendations for emerging good practice and future research in relation to family and caregiver health spillovers in health economic 8 evaluations: a report of the SHEER task force
- Including carer health-related quality of life in NICE health technology assessments in the United Kingdom
- A systematic review of methods and practice for integrating maternal, fetal, and child health outcomes, and family spillover effects into cost-utility analyses
- Family spillover effects: are economic evaluations misrepresenting the value of healthcare interventions to society?
- Toward a broader concept of societal value: family spillovers in Alzheimer's disease
- Carers’ health-related quality of life in global health technology assessment: guidance, case studies and recommendations
- Systematic review of cost-utility analyses that have included carer and family member health-related quality of life
- Environmental impact
- Main challenges of incorporating environmental impacts in the economic evaluation of health technology assessment: a scoping review
- Incorporating carbon into health care: adding carbon emissions to health technology assessments
- Assessing the social and environmental impact of healthcare technologies: Towards an extended social return on investment
- Incorporating environmental and sustainability considerations into health technology assessment and clinical and public health guidelines: a scoping review
- Environmental impact assessment in health technology assessment: principles, approaches, and challenges
- How can environmental impacts be incorporated in health technology assessment, and how impactful would this be?
- Methods to include environmental impacts in health economic evaluations and health technology assessments: a scoping review
- International landscape and current practices
- The evolving nature of Health Technology Assessment: A critical appraisal of NICE’s new methods manual
- Meta-analysis of economic evaluation studies: data harmonisation and methodological issues
- Good practices for health technology assessment guideline development: a report of the Health Technology Assessment International, HTAsiaLink, and ISPOR special task force
- A call to action to harmonize patient-reported outcomes evidence requirements across key European HTA bodies in oncology
- HTA302 Consideration of Societal and Equity-Based Value Attributes (VAs) by the National Institute for Health and Care Excellence (NICE) During Evaluation of Innovative Technologies in 2023
- Implementing the EU HTA Regulation: Insights from semi-structured interviews on patient expectations, Belgian and European institutional perspectives, and industry outlooks
- Challenges of health technology assessment in pluralistic healthcare systems: an ISPOR Council Report
- Harmonizing HTA evidence needs and expectations: challenges and opportunities to improve evidence generation, ensure access and affordability
- Harmonization issues in unit costing of service use for multi-country, multi-sectoral health economic evaluations: a scoping review
- Towards a European harmonization of health technology assessment recommendations executive paper of European regulatory conference focused on the EU commission proposal to harmonize HTA
- Recommendations for patient involvement in health technology assessment in Central and Eastern European countries
- The current landscape of HTA framework and key challenges
- Algorithms and heuristics of health technology assessments: a retrospective analysis of factors associated with HTA outcomes for new drugs across seven OECD countries
- Including carer health-related quality of life in NICE health technology assessments in the United Kingdom
- Expanding health technology assessment towards broader value: Ireland as a case study
- EE4 Should NICE Consider Adoption of a Societal Perspective? Comparison of the ICER 2023 Value Assessment Framework with the NICE 2022 Methods Guide
- Public value and digital health: The example of guiding values in the national digital health strategy of France
- What is needed to successfully implement the EU HTA Regulation enabling broad patient access in Europe
- Health Technology Assessment (HTA) Using MAFEIP (Monitoring and Assessment Framework for the European Innovation Partnership on Active and Healthy Ageing)
- The development of a new approach for the harmonized multi-sectoral and multi-country cost valuation of services: the PECUNIA reference unit cost (RUC) templates
- Factors influencing the institutionalization of health technology assessment: a scoping literature review
- Multistakeholder perceptions of additional value elements for United States value assessment of health interventions
- Societal Versus Healthcare Perspectives on the Cost Effectiveness of Ocrelizumab for Treatment of Primary Progressive Multiple Sclerosis in Aotearoa New Zealand
- Institutional Country-Specific Context and Value Drivers in Health Technology Assessment: A European Perspective
- Challenges and reforms in Spain’s health technology assessment system: analysis of criteria influencing medicines’ reimbursement decisions between 2019 and 2022 in Spain
- Mapping methods gaps between EU joint clinical assessments and local health technology assessment decision-making: an environmental scan of guidance in select EU markets and harmonization challenges
- EU HTA regulation and joint clinical assessment—threat or opportunity?
- Valuing the Societal Impact of Medicines and Other Health Technologies: A User Guide to Current Best Practices
- Methodological advancements in costing methods for (public) health economic evaluations: results from the European PECUNIA project
- An overview of the perspectives used in health economic evaluations
- OD14 Harmonization Of HTA For Digital Health Technologies: The EU-Funded European Digital Health Technology Assessment Project
- Ensuring the Efficiency and Effectiveness of Joint Clinical Assessment in National HTA Decision-Making: Insights from the 2024 CIRS Multi-Stakeholder Workshop